Literature DB >> 8544970

Serum levels of carnitine in chronic fatigue syndrome: clinical correlates.

A V Plioplys1, S Plioplys.   

Abstract

Carnitine is essential for mitochondrial energy production. Disturbance in mitochondrial function may contribute to or cause the fatigue seen in chronic fatigue syndrome (CFS) patients. One previous investigation has reported decreased acylcarnitine levels in 38 CFS patients. We investigated 35 CFS patients (27 females and 8 males); our results indicate that CFS patients have statistically significantly lower serum total carnitine, free carnitine and acylcarnitine levels, not only lower acylcarnitine levels as previously reported. We also found a statistically significant correlation between serum levels of total and free carnitine and clinical symptomatology. Higher serum carnitine levels correlated with better functional capacity. These findings may be indicative of mitochondrial dysfunction, which may contribute to or cause symptoms of fatigue in CFS patients.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8544970     DOI: 10.1159/000119226

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  15 in total

Review 1.  Neuromuscular and systemic presentations in adults: diagnoses beyond MERRF and MELAS.

Authors:  Bruce H Cohen
Journal:  Neurotherapeutics       Date:  2013-04       Impact factor: 7.620

2.  Characteristics of chronic fatigue syndrome in a Japanese community population : chronic fatigue syndrome in Japan.

Authors:  Masahide Hamaguchi; Yutaka Kawahito; Noriyuki Takeda; Takahiro Kato; Takao Kojima
Journal:  Clin Rheumatol       Date:  2011-02-08       Impact factor: 2.980

Review 3.  The Link Between Energy-Related Sensations and Metabolism: Implications for Treating Fatigue.

Authors:  Marco Filippi; Rainer Krähenmann; Patrick Fissler
Journal:  Front Psychol       Date:  2022-06-21

Review 4.  Chronic fatigue syndrome: Harvey and Wessely's (bio)psychosocial model versus a bio(psychosocial) model based on inflammatory and oxidative and nitrosative stress pathways.

Authors:  Michael Maes; Frank N M Twisk
Journal:  BMC Med       Date:  2010-06-15       Impact factor: 8.775

5.  Chronic fatigue syndrome and mitochondrial dysfunction.

Authors:  Sarah Myhill; Norman E Booth; John McLaren-Howard
Journal:  Int J Clin Exp Med       Date:  2009-01-15

6.  Epidemiological study air disaster in Amsterdam (ESADA): study design.

Authors:  Pauline Slottje; Anja C Huizink; Jos W R Twisk; Anke B Witteveen; Henk M van der Ploeg; Inge Bramsen; Nynke Smidt; Joost A Bijlsma; Lex M Bouter; Willem van Mechelen; Tjabe Smid
Journal:  BMC Public Health       Date:  2005-05-30       Impact factor: 3.295

7.  Association of Mitochondrial Dysfunction and Fatigue: A Review of the Literature.

Authors:  Kristin Filler; Debra Lyon; James Bennett; Nancy McCain; Ronald Elswick; Nada Lukkahatai; Leorey N Saligan
Journal:  BBA Clin       Date:  2014-06-01

8.  Effects of oral L-carnitine administration in narcolepsy patients: a randomized, double-blind, cross-over and placebo-controlled trial.

Authors:  Taku Miyagawa; Hiromi Kawamura; Mariko Obuchi; Asuka Ikesaki; Akiko Ozaki; Katsushi Tokunaga; Yuichi Inoue; Makoto Honda
Journal:  PLoS One       Date:  2013-01-17       Impact factor: 3.240

9.  Effects of Citric Acid and l-Carnitine on Physical Fatigue.

Authors:  Tomohiro Sugino; Sayaka Aoyagi; Tomoko Shirai; Yoshitaka Kajimoto; Osami Kajimoto
Journal:  J Clin Biochem Nutr       Date:  2007-11       Impact factor: 3.114

Review 10.  Efficacy of rintatolimod in the treatment of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME).

Authors:  William M Mitchell
Journal:  Expert Rev Clin Pharmacol       Date:  2016-06       Impact factor: 5.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.